ABN AMRO Bank N.V.

Bank

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1561082 AMSTERDAM, P7

Position in VRTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$62,573,078

+$9,725,516 QoQ

Shares Held

125,970

+6.4% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#157

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ABN AMRO Bank N.V. holds $64,116,396 across 3 Biotechnology names. VRTX ranks #1 (97.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	125,970	$62,573,078
2	RPRX	Royalty Pharma plc	19,985	$1,120,558
3	REGN	Regeneron Pharmaceuticals, Inc.	678	$422,760

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$62,573,078	125,970	+6.4%	Shares	Sole	2026-08-06
2026-03-31	$52,847,562	118,349	-23.8%	Shares	Sole	2026-04-22
2025-12-31	$70,370,992	155,221	+9.4%	Shares	Sole	2026-02-04
2025-09-30	$55,562,358	141,871	+6.6%	Shares	Sole	2025-11-05
2025-06-30	$59,243,654	133,072	+4.5%	Shares	Sole	2025-08-12
2025-03-31	$61,762,674	127,393	+2.7%	Shares	Sole	2025-08-28
2024-12-31	$49,955,740	124,052	+6.3%	Shares	Sole	2025-08-28
2024-09-30	$54,260,418	116,669	+2.8%	Shares	Sole	2025-08-28
2024-06-30	$53,208,625	113,519	+2.0%	Shares	Sole	2025-08-28
2024-03-31	$46,541,651	111,341	+6.8%	Shares	Sole	2025-08-28
2023-12-31	$42,403,634	104,214	+7.7%	Shares	Sole	2025-08-28
2023-09-30	$33,640,715	96,741	+2.1%	Shares	Sole	2025-08-28
2023-06-30	$33,336,786	94,731	+1.9%	Shares	Sole	2025-08-28
2023-03-31	$29,299,619	92,994	—	Shares	Sole	2025-08-28
No filing history on record for this holder in this stock.